archiveXPAND

The logo of Danish drugmaker Novo Nordisk, Copenhagen, Denmark, September 26, 2023. REUTERS/Tom Little/File Photo Acquire Licensing RightsLONDON/COPENHAGEN, Nov 10 (Reuters) - Obesity drug maker Novo Nordisk (NOVOb.CO) said on Friday it will spend $6 billion to boost production in Denmark, although its chief executive warned the industry was far from being able to produce enough weight-loss drugs to meet global demand.Novo Nordisk has had phenomenal success with its anti-obesity drug, Wegovy, but has scrambled to address shortages that have forced it to limit the number of patients.The World Health...

A view of the British capital's twin financial powerhouse, the City of London and Canary Wharf, in London, Britain March 19, 2023. REUTERS/Yann Tessier/File Photo Acquire Licensing RightsLONDON, Oct 16 (Reuters) - Brookfield (BN.TO), through its affiliate Brookfield Reinsurance (BNRE.N), is weighing entering Britain's burgeoning pension insurance industry and is open to an acquisition to bolster growth, three people familiar with the matter told Reuters. The company is scanning the market for potential deals to access the bulk annuities space, where possible targets could include companies like Just Group (JUSTJ.L)...